Zoetis names Jay Saccaro EVP, CFO and COO, effective August 17, 2026
Wetteny Joseph, the outgoing CFO, will stay on as a special advisor to the CEO through early 2027 under a transition agreement.
Zoetis Inc. disclosed in an August 6, 2026 8-K that James (Jay) Saccaro has been appointed Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026.1 The company said this is a newly created role, and Saccaro will oversee Zoetis's global finance operations along with capital allocation, financial reporting and controls, investor engagement, and Global Manufacturing and Supply, while also serving as principal financial officer and principal accounting officer.1
Saccaro, age 53, most recently served as Vice President and Chief Financial Officer of GE HealthCare Technologies Inc. since June 2023.1 Before that, he was Executive Vice President and Chief Financial Officer of Baxter International Inc. between July 2015 and May 2023.1 He holds a bachelor's degree in economics and a master's degree in engineering-economic systems from Stanford University.1
Under an offer letter dated July 31, 2026, Saccaro will receive a base salary of $1,000,000, a target annual incentive of 100% of base salary, and a target long-term incentive opportunity of $5,000,000, split among performance stock units, restricted stock units, and stock options.1 He will also get a one-time make-whole restricted stock unit award valued at $6,250,000 vesting over three years, and a one-time cash award of $1,250,000 subject to repayment if he leaves within his first year.1
Outgoing CFO Wetteny Joseph will step down from his executive role and, under a separate letter agreement, remain employed in a non-executive advisory capacity through the earlier of February 28, 2027 or a mutually agreed date.1 The filing states his departure did not stem from any disagreement over the company's operations, policies, accounting, or internal controls.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.